PHI Pharmacist : DR-TB TREATMENT AND CARE
- Drug-Resistant Tuberculosis [DR-TB]
- Goals of DR-TB Treatment
- Screening for DR-TB
- Types of Drug Resistance Tuberculosis -DRTB
- DR-TB Treatment Regimens
- Pre-treatment Evaluation [PTE] of DR-TB Patients
- Second Line anti TB drugs
- Newer Anti-TB Drugs
- Weight Band-wise Dosages of DR-TB Drugs for Adults
- Treatment of DR-TB in Children
- ADRs to Second Line Treatment
- Reporting of Adverse Events and Serious Adverse Events
PHI-Pharmacist: TB and TB Epidemiology
- Tuberculosis [TB]
- Global Burden of TB
- Burden of TB in India
- TB Causative organism
- Mode of TB Transmission
- Determinants of TB Disease
- Vulnerable Population for Tuberculosis
- TB Infection
- Progression to TB Disease
- TB Infection Vs Active TB Disease
- Chemotherapy and its implication in TB control
- Prevention of TB
Ph-Module 2: TB Treatment
- Ph-Ch6: General concepts in TB Treatment
- Ph-Ch7: DS-TB Treatment and care
- Ph-Ch8: DR-TB Treatment and care
- Ph-Ch9: Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen
- Ph-Ch10: Longer Oral M/XDR-TB Regimen
- Ph-Ch11: Isoniazid (H) Mono/Poly DR-TB Regimen
- Ph-Ch12: TB Infection treatment and care
- Ph-Ch13: TB-Comorbidities and special situations
- Ph-Ch14: General Concepts in Adherence Managament